The decline in Yield10 Bioscience's stock price is directly tied to the market's reaction to their Q4 financial results. Typically, financial results can significantly impact a company's stock price in the short term, depending on whether they meet, exceed, or fall short of market expectations. In this case, the negative reaction suggests that the results may have been below market expectations.